In late June, the state research center of Virology and biotechnology “Vector” plans to begin clinical trials of a vaccine against coronavirus COVID-19.

the testing will involve three promising drug, says TASS with reference to General Director of “Vector” Rinat Maksutov.

the Test will start June 29 — immediately after approval is received, Ministry of health of Russia and will receive the results of tests of the vaccine on animals. Maksyutov noted that the development and testing of vaccines was proceeding on schedule.